Shanghai Fosun Pharmaceutical (Group) Co., the distributor of the Pfizer-BioNTech COVID-19 vaccine in the Greater China area, has insisted that any sale of the vaccine to Taiwan, either to the government or a private company, will have to go through its distribution network, according to a report on a Chinese investment and trading platform.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Chiayi sesame oil maker ordered to suspend operations over carcinogen
08/26/2026 08:40 PM - Politics
Legislature to vote on competing drone procurement bills Thursday
08/26/2026 08:33 PM - Culture
Museum to open comic exhibition inspired by Taiwanese folk culture
08/26/2026 08:16 PM - Science & Tech
Formosan flying fox colony thrives in urban Hualien on old trees: Study
08/26/2026 07:44 PM - Business
Taiwan industries should follow electricity supply in AI era: Executive
08/26/2026 05:49 PM